GLYC - GlycoMimetics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
12.40
-0.07 (-0.56%)
As of 11:46AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close12.47
Open12.54
Bid12.43 x 400
Ask12.46 x 100
Day's Range12.13 - 12.62
52 Week Range3.82 - 16.94
Volume112,000
Avg. Volume508,144
Market Cap425.79M
Beta3.38
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Yahoo Finance Contributors6 months ago

    Trade to your strengths…..no really do this

  • Thomson Reuters StreetEvents13 days ago

    Edited Transcript of GLYC earnings conference call or presentation 8-Nov-17 1:30pm GMT

    Q3 2017 GlycoMimetics Inc Earnings Call

  • Associated Press13 days ago

    GlycoMimetics reports 3Q loss

    The Rockville, Maryland-based company said it had a loss of 24 cents per share. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ...

  • Why Earnings Season Could Be Great for GlycoMimetics (GLYC)
    Zacks19 days ago

    Why Earnings Season Could Be Great for GlycoMimetics (GLYC)

    GlycoMimetics' (GLYC) favorable Zacks Rank #3 (Hold) and positive ESP enhances its potential for a beat.

  • Capital Cubelast month

    GlycoMimetics, Inc. – Value Analysis (NASDAQ:GLYC) : October 17, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives GlycoMimetics, Inc. a score of 21. Our analysis is based on comparing GlycoMimetics, Inc. with the following peers – bluebird bio, Inc., Sanofi Sponsored ADR, Eiger BioPharmaceuticals, Inc., Savara, Inc., Pfizer Inc., Palatin Technologies, Inc. and Johnson & Johnson (BLUE-US, SNY-US, EIGR-US, SVRA-US, PFE-US, PTN-US and JNJ-US). ... Read more (Read more...)

  • GlycoMimetics, Inc. breached its 50 day moving average in a Bearish Manner : GLYC-US : October 16, 2017
    Capital Cubelast month

    GlycoMimetics, Inc. breached its 50 day moving average in a Bearish Manner : GLYC-US : October 16, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for GlycoMimetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • GlycoMimetics (GLYC) in Focus: Stock Moves 9.2% Higher
    Zacks2 months ago

    GlycoMimetics (GLYC) in Focus: Stock Moves 9.2% Higher

    GlycoMimetics (GLYC) was a big mover last session, as the company saw its shares rise more than 9% on the day amid huge volumes.

  • GlycoMimetics, Inc. breached its 50 day moving average in a Bearish Manner : GLYC-US : September 11, 2017
    Capital Cube2 months ago

    GlycoMimetics, Inc. breached its 50 day moving average in a Bearish Manner : GLYC-US : September 11, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for GlycoMimetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Can GlycoMimetics (GLYC) Run Higher on Strong Earnings Estimate Revisions?
    Zacks3 months ago

    Can GlycoMimetics (GLYC) Run Higher on Strong Earnings Estimate Revisions?

    GlycoMimetics (GLYC) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision, along with decent short-term momentum.

  • GlycoMimetics, Inc. breached its 50 day moving average in a Bullish Manner : GLYC-US : August 25, 2017
    Capital Cube3 months ago

    GlycoMimetics, Inc. breached its 50 day moving average in a Bullish Manner : GLYC-US : August 25, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for GlycoMimetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • GlycoMimetics, Inc. breached its 50 day moving average in a Bullish Manner : GLYC-US : August 8, 2017
    Capital Cube3 months ago

    GlycoMimetics, Inc. breached its 50 day moving average in a Bullish Manner : GLYC-US : August 8, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for GlycoMimetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Associated Press4 months ago

    GlycoMimetics reports 2Q loss

    On a per-share basis, the Rockville, Maryland-based company said it had a loss of 30 cents. The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...

  • GlycoMimetics, Inc. – Value Analysis (NASDAQ:GLYC) : August 1, 2017
    Capital Cube4 months ago

    GlycoMimetics, Inc. – Value Analysis (NASDAQ:GLYC) : August 1, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives GlycoMimetics, Inc. a score of 21. Our analysis is based on comparing GlycoMimetics, Inc. with the following peers – bluebird bio, Inc., Sanofi Sponsored ADR, Eiger BioPharmaceuticals, Inc., Savara, Inc., Pfizer Inc., Palatin Technologies, Inc. and Johnson & Johnson (BLUE-US, SNY-US, EIGR-US, SVRA-US, PFE-US, PTN-US and JNJ-US). ... Read more (Read more...)

  • GlycoMimetics, Inc. breached its 50 day moving average in a Bullish Manner : GLYC-US : July 19, 2017
    Capital Cube4 months ago

    GlycoMimetics, Inc. breached its 50 day moving average in a Bullish Manner : GLYC-US : July 19, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for GlycoMimetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Zacks5 months ago

    Are Options Traders Betting on a Big Move in GlycoMimetics (GLYC) Stock?

    Investors in GlycoMimetics, Inc. (GLYC) need to pay close attention to the stock based on moves in the options market lately.

  • Why GlycoMimetics Is Tumbling 13.4% Today
    Motley Fool6 months ago

    Why GlycoMimetics Is Tumbling 13.4% Today

    New data from a trial evaluating one of its most promising drug candidates failed to impress investors.

  • Here's Why GlycoMimetics Rose as Much as 21% Today
    Motley Fool6 months ago

    Here's Why GlycoMimetics Rose as Much as 21% Today

    The stock received yet another piece of good news this month -- this time, from Europe.

  • TheStreet.com6 months ago

    Shark Bites: There Wasn't Even a Dip to Buy

    Action runs counter to pattern, leaving market players wondering what to do.

  • Capital Cube6 months ago

    ETFs with exposure to GlycoMimetics, Inc. : May 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to GlycoMimetics, Inc. Here are 5 ETFs with the largest exposure to GLYC-US. Comparing the performance and risk of GlycoMimetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Why GlycoMimetics Is Ripping 19% Higher Today
    Motley Fool6 months ago

    Why GlycoMimetics Is Ripping 19% Higher Today

    Optimism over a mid-stage leukemia drug in development is causing shares to climb this week.

  • GlycoMimetics (GLYC) Shows Strength: Stock Jumps 98.7%
    Zacks6 months ago

    GlycoMimetics (GLYC) Shows Strength: Stock Jumps 98.7%

    GlycoMimetics, Inc. (GLYC) shares skyrocketed to almost 99% in the last trading session.

  • Zacks6 months ago

    Here's Why GlycoMimetics (GLYC) Stock Skyrocketed Over 100% Today

    On Thursday, shares of biotech company GlycoMimetics Inc. (GLYC) are skyrocketing, up over 100% to $10.92 per share in afternoon trading after the company announced that the FDA designated one of its drugs as a "Breakthrough Therapy."

  • TheStreet.com6 months ago

    Don't Trust the Bounce Yet

    It feels like there is some squeeze action taking place now.

  • Associated Press6 months ago

    GlycoMimetics reports 1Q loss

    On a per-share basis, the Rockville, Maryland-based company said it had a loss of 34 cents. The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...

  • Capital Cube8 months ago

    ETFs with exposure to GlycoMimetics, Inc. : April 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to GlycoMimetics, Inc. Here are 5 ETFs with the largest exposure to GLYC-US. Comparing the performance and risk of GlycoMimetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)